Signaling Pathways - potassium channel - MAGL - Myosin light chain kinases (MLCKs) - GABAA Receptors
清除全部
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂
- A8435 Furosemide中文名: 呋塞米Target: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA受体拮抗剂
- A2917 Flumazenil中文名: 氟马西尼Target: GABAA ReceptorsSummary: 苯二氮卓拮抗剂
- A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂
- A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂
- N1846 Tanshinone IIA中文名: 丹参酮IIATarget: AP-1|MAGLSummary: 抗氧化和抗炎剂